Get started
Author

Wesley H. Witteles

Observed names: W. Witteles, Wesley Witteles
OpenAlex ID: A5047098006
Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors
2019 · Rebecca Karp Leaf, Christopher Ferreri, et al. · American Journal of Hematology · 86
Lenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain amyloidosis with high rates of advanced cardiac involvement
2013 · S. Dinner, W. Witteles, et al. · Haematologica · 62
PDF
The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis
2013 · Shira Dinner, Wesley Witteles, et al. · British Journal of Haematology · 41
Lung Cancer Presenting With Amegakaryocytic Thrombocytopenia
2008 · Wesley H. Witteles, Stanley L. Schrier, et al. · Journal of Clinical Oncology · 8
Longitudinal study of 2 patients with cyclic thrombocytopenia, STAT3 and MPL mutations
2022 · Haiyu Zhang, May Chien, et al. · Blood Advances · 7
Clinical Features of Immune Checkpoint Inhibitor-Associated Autoimmune Hemolytic Anemia: A Series of 14 Cases
2018 · Rebecca Karp Leaf, Christopher Ferreri, et al. · Blood · 1
A Pilot Study of Melphalan, Lenalidomide and Dexamethasone In AL Amyloidosis: Interim Results
2010 · Anosheh Afghahi, Wesley Witteles, et al. · Blood · 1
AL Amyloidosis and Concomitant Myeloma: Time to Reconsider Assumptions
2010 · Wesley Witteles, Ronald Witteles, et al. · Blood
AL Amyloidosis: Prognosis of Cardiac Involvement Reconsidered.
2009 · Wesley Witteles, Ronald Witteles, et al. · Blood
Large Granular Lymphocyte Leukemia: Clonality Reconsidered.
2007 · Wesley Witteles, Bing Zhang, et al. · Blood
Robust Anti-Leukemia CD4+ and CD8+ T Cell Responses in CML Patients Treated with Imatinib Mesylate.
2006 · Christiane I.-U. Chen, Alexandre Johannsen, et al. · Blood
Works count: 11
Citation count: 206
H-index: 5
I10-index: 3
Year
Topic
Type